Cerebrovascular event (CVE) outcome and overall survival (OS) in patients (pts) treated with sipuleucel-T (sip-T) for metastatic castration-resistant prostate cancer (mCRPC): Results from the PROCEED registry Meeting Abstract


Authors: Higano, C. S.; Armstrong, A. J.; Sartor, A. O.; Vogelzang, N. J.; Kantoff, P. W.; McLeod, D. G.; Pieczonka, C. M.; Penson, D. F.; Shore, N. D.; Vacirca, J. L.; Concepcion, R. S.; Tutrone, R. F.; Nordquist, L. T.; Quinn, D. I.; Kassabian, V.; Scholz, M. C.; Tyler, R. C.; Chang, N. N.; Brown, B.; Cooperberg, M. R.
Abstract Title: Cerebrovascular event (CVE) outcome and overall survival (OS) in patients (pts) treated with sipuleucel-T (sip-T) for metastatic castration-resistant prostate cancer (mCRPC): Results from the PROCEED registry
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Language: English
ACCESSION: WOS:000442916005456
DOI: 10.1200/JCO.2018.36.15_suppl.e17018
PROVIDER: wos
Notes: Meeting Abstract: e17018 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Philip Wayne Kantoff
    197 Kantoff